Frequency of Erectile Dysfunction in Metabolic Syndrome Patients

Basit Öğe Kaydı
dc.authoridUnal, Mustafa/0000-0001-6640-6298
dc.contributor.authorUnal, Mustafa
dc.contributor.authorAydin, Yusuf
dc.contributor.authorUstun, Ihsan
dc.contributor.authorBerker, Dilek
dc.contributor.authorErol, Kutlu
dc.contributor.authorGul, Kamile
dc.contributor.authorGuler, Serdar
dc.date.accessioned2024-09-18T20:32:46Z
dc.date.available2024-09-18T20:32:46Z
dc.date.issued2014
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractPurpose: Metabolic syndrome (MS) is the most important clinical situation which predisposes the endotelial dysfunction and atherosclerosis. Nitric oxid (NO) loss is an important finding in the early stages of endothelial dysfunction. NO deficiency results erectile dysfunction (ED) signs and symptoms. We aim in this study to assess the frequency of the ED in MS patients. Method: This study includes 43 MS patients who fullfill NCEP-ATP III criteria and 29 healthy subjects. A signed permission form was taken from all of the participants. Biochemical and hormonal parameters such as fasting bood glucose (FBG), postprandial glucose (PPG), total testosterone (TT), insulin, high sensitive CRP, total cholesterol (TC), triglyceride (Tg), low density lipoprotein (LDL), high density liporotein (HDL) were measured from the blood which was taken after 12 hours fasting period. ED was evaluated by the questionnaire of International Index of Erectile Function-5 (IIEF-5) which was answered by the included subjects. Insulin resistance was calculated by HOMA-IR method by the formula of FBGxinsulin/405. Results: ED was detected in 65% of the MS group and in 13,8% of the control group. ED was divided into subgroups according to the severity. In MS patients; 18,6% had mild ED, 14% had mild-moderate ED, 14% had moderate ED and 14% had severe ED but in control group only 13,8% of them had mild ED. Although HOMA-IR value was 3,56 +/- 3,45 in MS patients with ED, it was 2,23 +/- 1,72 in patients without ED (p= 0,034). In MS patients with and without ED testosterone levels were measured as 4,5 +/- 1 and 6,1 +/- 1,56, respectively (p< 0,001). Conclusion: ED is highly prevelant in patients with MS and MS patients with ED have low testosterone levels and high HOMA-IR levels which shows insulin resistance.en_US
dc.identifier.endpage16en_US
dc.identifier.issn1309-3878
dc.identifier.issue1en_US
dc.identifier.startpage11en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/11103
dc.identifier.volume6en_US
dc.identifier.wosWOS:000420977700003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherDuzce Univen_US
dc.relation.ispartofKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectErectile Dysfunctionen_US
dc.subjectInsulin Resistanceen_US
dc.titleFrequency of Erectile Dysfunction in Metabolic Syndrome Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu